Humacyte, Inc. Inventory
Humacyte, Inc. (HUMA) had Inventory of $6.99 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2026-08-12
- 2026-06-30: Inventory, Net $6.99M.
- 2026-03-31: Inventory, Net $9.92M.
- 2025-12-31: Inventory, Net $13.59M.
- 2025-09-30: Inventory, Net $18.42M.
| Period end | Inventory, Net |
|---|---|
| 2026-06-30 | $6.99M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $9.92M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $13.59M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $18.42M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $11.07M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $8.02M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |